Kodiak Sciences Inc (KOD)
Healthcare
Biotechnology
39.80 $
-4.2%
vs. previous close
Closing price · As of: 3. Aug 2026
Kodiak Sciences Inc (KOD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -40 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -42 | -33 | -32 | -40 | -26 | -21 | -30 | -29 | -35 | -33 | -39 | -40 | -147 | |
| 6.7 | 7.0 | 6.7 | 6.6 | 6.7 | 6.7 | 6.7 | 6.7 | 6.5 | 6.5 | -1.5 | 6.3 | 18 | |
| 26 | 14 | 23 | 18 | 18 | 15 | 8.6 | 16 | 16 | 14 | 27 | 12 | 69 | |
| 25 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 6.4 | -3.7 | -2.5 | -22 | -6.6 | 1.3 | -1.3 | 3.8 | -2.5 | 8.0 | -2.5 | -0.3 | 2.7 | |
| 1.5 | 0.2 | 27 | 0.0 | 0.0 | 0.2 | 0.1 | 0.3 | 0.1 | 0.1 | 0.0 | 0.9 | 1.2 | |
| 104 | -0.2 | -28 | -0.2 | -0.3 | -0.2 | -0.1 | -0.3 | -0.1 | -0.1 | 0.0 | -0.9 | -1.2 | |
| 0.2 | – | – | – | – | 0.1 | – | – | – | – | – | – | – | |
| 0.2 | 0.0 | -0.1 | 0.0 | 0.1 | 0.0 | 0.4 | 0.1 | 0.1 | 0.8 | 177 | 0.6 | 179 | |
| 62 | -33 | -60 | -40 | -27 | -21 | -30 | -29 | -35 | -32 | 138 | -40 | 31 | |
| -43 | -33 | -60 | -40 | -27 | -21 | -30 | -29 | -35 | -33 | -39 | -41 | -148 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.